Midlife Cholesterol Study
Completed · Phase 4
Conditions studied: Menopause, Postmenopause, Premenopause, Cardiovascular Disease
In brief
The postmenopausal state is associated with an increase risk for heart disease. Much of this increase in risk may be due to the loss of estrogen (the main female hormone) and the effect of this loss on lipids (blood fats). This loss of estrogen is often treated by estrogen replacement therapy. Estrogen replacement therapy seems to have a beneficial effect on lipid levels. The purpose of this research study is to understand 1) how menopause affects lipids and 2) how hormone replacement therapy effects the lipid metabolism of postmenopausal women.
Key facts
- Study ID
- NCT00361075
- Run by
- Northwestern University
- People needed
- 120
- Starts
- 1998-07-01
- Expected to finish
- 2005-05-01
- Last updated by the study team
- 2014-11-05
Who can join
Age: 47 and older, up to 55. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Have demonstrated an interest to participate in the ERT trial
- Be premenopausal (have menstrual period in previous three months) prior to start of observational arm
- Prior to start of interventional arm (ERT), the women must be postmenopausal (have not had a menstrual cycle in the past twelve months and FSH >30)
- Be between the ages of 47 and 55
- Not be taking any form of estrogen replacement
- Have an intact uterus and at least one ovary and normal screening mammogram in the 12 months prior to starting ERT
You may not qualify if…
- Body mass index (kg/m2) greater than 40 kg/m2
- History of diabetes mellitus or fasting >110 mg/dl at screening
- Abnormal fasting LDL or triglyceride
- Use of lipid lowering medications, beta-blockers, birth control pills
- Active liver disease (recent history of active hepatitis, jaundice, scleral icterus, and/or elevated liver function tests
- History of breast, endometrial or ovarian cancer
- History of thrombotic disorder (past history of pulmonary embolus or deep venous thrombosis) or known history of CAD
Where it is running
- Northwestern University — Chicago, Illinois, United States
- University of Washington — Seattle, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.